ScholarIQanswers from OpenAlex & ORCID
David F. Ransohoff
ResearcherPublications, citations & collaboration network
David F. Ransohoff is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David F. Ransohoff have?
ScholarIQindexed works
David F. Ransohoff has 295 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David F. Ransohoff have?
ScholarIQcitation count
David F. Ransohoff has 32,042 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David F. Ransohoff?
ScholarIQh-index
David F. Ransohoff has an h-index of 74 in OpenAlex.
What is the i10-index of David F. Ransohoff?
ScholarIQi10-index
David F. Ransohoff has an i10-index of 149 in OpenAlex.
What is the ORCID of David F. Ransohoff?
ScholarIQorcid
The ORCID for David F. Ransohoff is on the source record.
What is the OpenAlex record for David F. Ransohoff?
ScholarIQopenalex
The OpenAlex for David F. Ransohoff is on the source record.
What are the most-cited papers on David F. Ransohoff?
ScholarIQmost cited works
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Hui Zhang, Tao Liu, Zhen Zhang, Samuel Payne, Bai Zhang, Jason McDermott, Jianying Zhou, Vladislav Petyuk, Li Chen, Debjit Ray, Shisheng Sun, Feng Yang, Lijun Chen, Jing Wang, Punit Shah, Seong Won, Paul Aiyetan, Sunghee Woo, Yuan Tian, Marina A. Gritsenko, Therese RW Clauss, Caitlin H. Choi, Matthew Monroe, Stefani N. Thomas, Song Nie, Chaochao Wu, Ronald Moore, Kun‐Hsing Yu, David L. Tabb, David Fenyö, Vineet Bafna, Yue Wang, Henry Rodriguez, Emily S. Boja, Tara Hiltke, Robert Rivers, Lori J. Sokoll, Heng Zhu, Ie‐Ming Shih, Leslie Cope, Akhilesh Pandey, Bing Zhang, M Snyder, Douglas A. Levine, Richard Smith, Daniel W. Chan, Daniel W. Chan, Karin D. Rodland, Karin D. Rodland, Steven A. Carr, Michael A. Gillette, Karl R. Klauser, Eric Kuhn, D.R. Mani, Philipp Mertins, Karen A. Ketchum, Ratna R. Thangudu, Shuang Cai, Mauricio Oberti, Amanda G. Paulovich, Jeffrey R. Whiteaker, Nathan Edwards, Peter B. McGarvey, Subha Madhavan, Pei Wang, Daniel W. Chan, Daniel W. Chan, Akhilesh Pandey, Ie‐Ming Shih, Hui Zhang, Zhen Zhang, Heng Zhu, Leslie Cope, Gordon A. Whiteley, Steven J. Skates, Forest M. White, Douglas A. Levine, Emily S. Boja, Christopher R. Kinsinger, Tara Hiltke, Mehdi Mesri, Robert C. Rivers, Henry Rodriguez, Kenna M. Shaw, Stephen E. Stein, David Fenyö, Tao Liu, Jason E. McDermott, Samuel Payne, Karin D. Rodland, Karin D. Rodland, Richard Smith, Paul A. Rudnick, M Snyder, Yingming Zhao, Xian Chen, David F. Ransohoff, Andrew N. Hoofnagle, D.C. Liebler, Melinda E. Sanders
Prospective evaluation of methylated <i>SEPT9</i> in plasma for detection of asymptomatic colorectal cancer
Timothy R. Church, Michael Wandell, Catherine Lofton–Day, Steven J. Mongin, Matthias Burger, Shannon R. Payne, Esmeralda Castaños‐Vélez, Brent A. Blumenstein, Thomas Rösch, Neal Osborn, Dale C. Snover, Robert Day, David F. Ransohoff
Nonpolypoid neoplastic lesions of the colorectal mucosa
S. Kudo, René Lambert, John I. Allen, Hiroaki Fujii, Takahiro Fujii, Hiroshi Kashida, Takahisa Matsuda, Masaki Mori, Hiroshi Saitō, Tadakazu Shimoda, Shinji Tanaka, Hidenobu Watanabe, Joseph J.�Y. Sung, Andrew D. Feld, John M. Inadomi, Michael J. O’Brien, David A. Lieberman, David F. Ransohoff, Roy Soetikno, George Triadafilopoulos, Ann G. Zauber, Cláudio Rolim Teixeira, J.-F. Rey, Edgar Jaramillo, Carlos Rubio‐Terres, A. Van Gossum, Michael Jung, Michael Vieth, Jeremy R. Jass, Paul Hurlstone
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
Laura J. Esserman, Ian M. Thompson, Brian J. Reid, Peter S. Nelson, David F. Ransohoff, H. Gilbert Welch, Shelley Hwang, Donald A. Berry, Kenneth W. Kinzler, William C. Black, Mina J. Bissell, Howard L. Parnes, Sudhir Srivastava